ArticleAnalytical chemistry2025
Multimodal Optical Imaging Combined with Radiomic Analysis for Fibrotic Cardiac Tissue Investigation.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the process of fibrotic scarring of the myocardium is critical for the diagnosis and risk stratification of life-threatening cardiac dysfunction. Complex changes in structure, composition, and conductivity occurring at different stages of fibrogenesis diversify the biomedical characteristics of the myocardium. We present a multimodal optical imaging approach including cardiac optical mapping (COM), optical coherence tomography (OCT), multiphoton microscopy (MPM), and line scan Raman microspectroscopy (LSRM) for multiparametric assessment of the myocardium with radiomic analysis to link electrophysiologic, morphologic, functional, and molecular changes in ischemic cardiac tissue and validate our results with histology. COM is used to map the electrical behavior across myocardial tissue. Second harmonic generation and two-photon excitation fluorescence imaging as MPM techniques provide additional unique contrast of collagen, the extracellular matrix, and cardiac cells, such as cardiomyocytes playing a critical role in cardiac fibrosis. Our machine learning model based on radiomic features extracted from MPM data addresses the need for automated fast high-throughput classification between healthy and pathologic cardiac tissues and achieved an accuracy of 0.99. In addition, LSRM assesses the molecular contrast and is used to evaluate the development stage of fibrotic scarring and multiclass classification by utilizing partial least-squares discriminant analysis, achieving sensitivity and specificity values of 0.94. OCT is used for fast navigation through the sample, for intermodal referencing, and easy coregistration between the complementary imaging techniques operating at different fields of view and resolutions ranging from cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.